Celldex Therapeutics, Inc. Total Shareholder Rtn Amt
Celldex Therapeutics, Inc. (CLDX) reported Total Shareholder Rtn Amt of $155 for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-29.
Financial Statements › Notes
ecd:TotalShareholderRtnAmt · last filed 2026-04-29
| Period end | Total Shareholder Rtn Amt 12 month |
|---|---|
| 2025-12-31 | $155.00 DEF 14A · filed 2026-04-29 |
| 2024-12-31 | $144.00 DEF 14A · filed 2026-04-29 |
| 2023-12-31 | $226.00 DEF 14A · filed 2026-04-29 |
| 2022-12-31 | $254.00 DEF 14A · filed 2026-04-29 |
| 2021-12-31 | $221.00 DEF 14A · filed 2026-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |